Lyell Immunopharma, Inc. Interest Income, Other
Lyell Immunopharma, Inc. (LYEL) reported Interest Income, Other of $270.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2021-11-12
- Lyell Immunopharma, Inc. interest income, other for the quarter ending 2021-09-30 was $270.00K, a 75.36% decline year-over-year.
- Lyell Immunopharma, Inc. interest income, other for the quarter ending 2021-06-30 was $218.00K, a 88.41% decline year-over-year.
- Lyell Immunopharma, Inc. interest income, other for the quarter ending 2020-09-30 was $1.10M.
- Lyell Immunopharma, Inc. interest income, other for the quarter ending 2020-06-30 was $1.88M.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month |
|---|---|---|---|
| 2021-09-30 | $270.00K 10-Q · filed 2021-11-12 | $488.00K derived: sum of 2 quarters · filed 2021-11-12 | $842.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $218.00K 10-Q · filed 2021-08-12 | $572.00K 10-Q · filed 2021-08-12 | |
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-12 | $2.98M derived: sum of 2 quarters · filed 2021-11-12 | $5.32M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $1.88M 10-Q · filed 2021-08-12 | $4.22M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |